Physician profile
Logan Campbell
NPI 1992068829
$4,535.32
in general payments reported to CMS, 2019-2025
40 companies · $382 in 2025
The $382 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $263 · 2020: $628 · 2021: $900 · 2022: $874 · 2023: $883 · 2024: $606 · 2025: $382.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,870.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,870.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $823.38 | 2020-2025 | Lupron Depot, Botox |
| Coloplast Corp | $693.85 | 2020-2024 | Speedicath |
| Boston Scientific Corporation | $642.12 | 2019-2025 | Ams 700, Ams 800 Artificial Urinary Sphincter, Axonics |
| Astellas Pharma US INC | $241.50 | 2019-2023 | Veozah |
| Teleflex LLC | $224.69 | 2021-2023 | Urolift |
| Janssen Biotech, INC. | $181.97 | 2022-2023 | Erleada |
| Medtronic, INC. | $130.23 | 2022-2025 | Interstim |
| Laborie Medical Technologies Corp. | $129.39 | 2023-2024 | Optilume Bph Drug Coated Balloon Catheter |
| Pfizer INC. | $110.36 | 2019-2023 | |
| Ferring Pharmaceuticals INC. | $101.70 | 2024-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $83.98 | 2023-2025 | Orgovyx, Gemtesa |
| Procept Biorobotics Corporation | $79.90 | 2020-2024 | Aquabeam Robotic System, Aquabeam System |
| Ethicon US, LLC | $79.73 | 2019-2025 | Enseal, Harmonic, Ultra Vac |
| Conmed Corporation | $79.71 | 2023 | Airseal |
| Novartis Pharmaceuticals Corporation | $73.28 | 2022-2024 |
Show all 40 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Caldera Medical, INC | $72.08 | 2021 | |
| Intuitive Surgical, INC. | $68.26 | 2022 | |
| Antares Pharma, INC. | $67.59 | 2019-2024 | Xyosted |
| Urogen Pharma, INC. | $60.27 | 2020-2024 | |
| Clarus Therapeutics INC. | $59.90 | 2021 | |
| Myovant Sciences INC. | $59.47 | 2021-2022 | |
| Travere Therapeutics, INC. | $56.37 | 2021 | |
| Allergan, INC. | $49.32 | 2020-2022 | |
| Amgen INC. | $36.00 | 2019 | |
| Tolmar, INC. | $34.41 | 2023-2025 | Eligard, Jatenzo |
| Urovant Sciences INC | $29.88 | 2022 | |
| Hollister Incorporated | $29.76 | 2021 | |
| Myriad Genetic Laboratories, INC. | $29.40 | 2021-2023 | Myrisk |
| Valencia Technologies Corporation | $24.04 | 2025 | Ecoin Device Kit |
| Genzyme Corporation | $23.29 | 2022 | |
| Blue Earth Diagnostics | $21.53 | 2021 | |
| Accord Healthcare, INC. | $16.99 | 2024 | |
| Tolmar Pharmaceuticals, INC. | $16.52 | 2019 | |
| Neotract INC. | $16.33 | 2020 | |
| Halozyme INC | $16.06 | 2023 | |
| Therapeuticsmd, INC. | $15.79 | 2019 | |
| Axonics, INC. | $15.24 | 2020 | |
| Endo Pharmaceuticals INC. | $15.01 | 2023 | Xiaflex |
| Olympus America INC. | $13.50 | 2019 | |
| Cook Medical LLC | $12.52 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Logan Campbell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.